Your shopping cart is empty!
U.S. FDA approves Osmolex ER (amantadine hydrochloride) Extended-Release Tablets
- Hits: 244
Osmotica Pharmaceutical US LLC receives FDA approval Osmolex ER (amantadine hydrochloride) Extended-Release Tablets
Company: Osmotica Pharmaceutical US LLC
Brand Name: Osmolex ER
Generic Name: amantadine hydrochloride
Dosage Form: Extended-Release Tablets
Treatment for: Parkinson’s Disease, Extrapyramidal Reaction
General information about Osmolex ER
Osmolex ER (amantadine hydrochloride) is a proprietary formulation of immediate release and extended release amantadine for the once-a-day treatment of Parkinson’s disease and drug-induced extrapyramidal reactions.